
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Intra-tumor heterogeneity from a cancer stem cell perspective
Pramudita R. Prasetyanti, Jan Paul Medema
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 658
Pramudita R. Prasetyanti, Jan Paul Medema
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 658
Showing 1-25 of 658 citing articles:
Exosome‐delivered circRNA promotes glycolysis to induce chemoresistance through the miR‐122‐PKM2 axis in colorectal cancer
Xinyi Wang, Haiyang Zhang, Haiou Yang, et al.
Molecular Oncology (2020) Vol. 14, Iss. 3, pp. 539-555
Open Access | Times Cited: 419
Xinyi Wang, Haiyang Zhang, Haiou Yang, et al.
Molecular Oncology (2020) Vol. 14, Iss. 3, pp. 539-555
Open Access | Times Cited: 419
Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
Xiufang Xu, Miaofeng Zhang, Faying Xu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 419
Xiufang Xu, Miaofeng Zhang, Faying Xu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 419
The epigenetic basis of cellular heterogeneity
Benjamin C. Carter, Keji Zhao
Nature Reviews Genetics (2020) Vol. 22, Iss. 4, pp. 235-250
Open Access | Times Cited: 239
Benjamin C. Carter, Keji Zhao
Nature Reviews Genetics (2020) Vol. 22, Iss. 4, pp. 235-250
Open Access | Times Cited: 239
WNT Signaling in Tumors: The Way to Evade Drugs and Immunity
Elena Martín‐Orozco, Ana Sanchez-Fernandez, Irene Ortiz-Parra, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 237
Elena Martín‐Orozco, Ana Sanchez-Fernandez, Irene Ortiz-Parra, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 237
Cancer stem cells (CSCs): metabolic strategies for their identification and eradication
Ernestina Marianna De Francesco, Federica Sotgia, Michael P. Lisanti
Biochemical Journal (2018) Vol. 475, Iss. 9, pp. 1611-1634
Open Access | Times Cited: 229
Ernestina Marianna De Francesco, Federica Sotgia, Michael P. Lisanti
Biochemical Journal (2018) Vol. 475, Iss. 9, pp. 1611-1634
Open Access | Times Cited: 229
Emerging role of tumor cell plasticity in modifying therapeutic response
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 197
Siyuan Qin, Jingwen Jiang, Yi Lü, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 197
Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
Venus Sosa Iglesias, Lorena Giuranno, Ludwig J. Dubois, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 190
Venus Sosa Iglesias, Lorena Giuranno, Ludwig J. Dubois, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 190
The Role of Cancer Stem Cells in Radiation Resistance
C. Arnold, Julian Mangesius, Ira Skvortsova, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 188
C. Arnold, Julian Mangesius, Ira Skvortsova, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 188
A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability
Peng‐Peng Zhu, Fang He, Yixuan Hou, et al.
Oncogene (2021) Vol. 40, Iss. 9, pp. 1609-1627
Open Access | Times Cited: 178
Peng‐Peng Zhu, Fang He, Yixuan Hou, et al.
Oncogene (2021) Vol. 40, Iss. 9, pp. 1609-1627
Open Access | Times Cited: 178
Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment
Belinda van Zyl, Denise Tang, Nikola A. Bowden
Endocrine Related Cancer (2018) Vol. 25, Iss. 5, pp. R303-R318
Open Access | Times Cited: 177
Belinda van Zyl, Denise Tang, Nikola A. Bowden
Endocrine Related Cancer (2018) Vol. 25, Iss. 5, pp. R303-R318
Open Access | Times Cited: 177
Role of tumor microenvironment in cancer progression and therapeutic strategy
Qingjing Wang, Xueting Shao, Yuxuan Zhang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11149-11165
Open Access | Times Cited: 175
Qingjing Wang, Xueting Shao, Yuxuan Zhang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11149-11165
Open Access | Times Cited: 175
Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies
Laura González-Silva, Laura Quevedo, Ignacio Varela
Trends in cancer (2020) Vol. 6, Iss. 1, pp. 13-19
Open Access | Times Cited: 171
Laura González-Silva, Laura Quevedo, Ignacio Varela
Trends in cancer (2020) Vol. 6, Iss. 1, pp. 13-19
Open Access | Times Cited: 171
Label-free chemical imaging flow cytometry by high-speed multicolor stimulated Raman scattering
Yuta Suzuki, Koya Kobayashi, Yoshifumi Wakisaka, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 32, pp. 15842-15848
Open Access | Times Cited: 165
Yuta Suzuki, Koya Kobayashi, Yoshifumi Wakisaka, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 32, pp. 15842-15848
Open Access | Times Cited: 165
PHGDH heterogeneity potentiates cancer cell dissemination and metastasis
Matteo Rossi, Patricia Altea‐Manzano, Margherita Demicco, et al.
Nature (2022) Vol. 605, Iss. 7911, pp. 747-753
Open Access | Times Cited: 147
Matteo Rossi, Patricia Altea‐Manzano, Margherita Demicco, et al.
Nature (2022) Vol. 605, Iss. 7911, pp. 747-753
Open Access | Times Cited: 147
Managing the TME to improve the efficacy of cancer therapy
Maria Teresa Bilotta, Antonella Antignani, David Fitzgerald
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 140
Maria Teresa Bilotta, Antonella Antignani, David Fitzgerald
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 140
An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment
Elena Verdugo, Iker Puerto, Miguel Ángel Medina
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1083-1111
Open Access | Times Cited: 119
Elena Verdugo, Iker Puerto, Miguel Ángel Medina
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1083-1111
Open Access | Times Cited: 119
DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer
Dalma Müller, Balázs Győrffy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188722-188722
Open Access | Times Cited: 116
Dalma Müller, Balázs Győrffy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 3, pp. 188722-188722
Open Access | Times Cited: 116
Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 105
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 105
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 976-976
Open Access | Times Cited: 93
Beatrice Aramini, Valentina Masciale, Giulia Grisendi, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 976-976
Open Access | Times Cited: 93
An Epigenetic Role of Mitochondria in Cancer
Yue Liu, Chao Chen, Xinye Wang, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2518-2518
Open Access | Times Cited: 87
Yue Liu, Chao Chen, Xinye Wang, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2518-2518
Open Access | Times Cited: 87
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance
Taniya Saha, Kiven Erique Lukong
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 81
Taniya Saha, Kiven Erique Lukong
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 81
Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy
Wenya He, Xiaozhe Li, Marco Morsch, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 6293-6308
Closed Access | Times Cited: 81
Wenya He, Xiaozhe Li, Marco Morsch, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 6293-6308
Closed Access | Times Cited: 81
Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
Sanae El Harane, Bochra Zidi, Nadia El Harane, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1001-1001
Open Access | Times Cited: 66
Sanae El Harane, Bochra Zidi, Nadia El Harane, et al.
Cells (2023) Vol. 12, Iss. 7, pp. 1001-1001
Open Access | Times Cited: 66
Cancer cell cycle heterogeneity as a critical determinant of therapeutic resistance
Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 189-204
Open Access | Times Cited: 63
Ebrahim H. Maleki, Ahmad Reza Bahrami, Maryam Moghaddam Matin
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 189-204
Open Access | Times Cited: 63
Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Zhen Zeng, Minyang Fu, Yuan Hu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 59
Zhen Zeng, Minyang Fu, Yuan Hu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 59